Literature DB >> 31629075

STrategically Acquired Gradient Echo (STAGE) imaging, part III: Technical advances and clinical applications of a rapid multi-contrast multi-parametric brain imaging method.

E Mark Haacke1, Yongsheng Chen2, David Utriainen3, Bo Wu4, Yu Wang5, Shuang Xia6, Naying He7, Chunyan Zhang8, Xiao Wang8, M Marcella Lagana9, Yu Luo10, Ali Fatemi11, Saifeng Liu12, Sara Gharabaghi4, Dongmei Wu13, Sean K Sethi14, Feng Huang15, Taotao Sun16, Feifei Qu17, Brijesh K Yadav17, Xiaoyue Ma18, Yan Bai18, Meiyun Wang19, Jingliang Cheng8, Fuhua Yan7.   

Abstract

One major thrust in radiology today is image standardization with a focus on rapidly acquired quantitative multi-contrast information. This is critical for multi-center trials, for the collection of big data and for the use of artificial intelligence in evaluating the data. Strategically acquired gradient echo (STAGE) imaging is one such method that can provide 8 qualitative and 7 quantitative pieces of information in 5 min or less at 3 T. STAGE provides qualitative images in the form of proton density weighted images, T1 weighted images, T2* weighted images and simulated double inversion recovery (DIR) images. STAGE also provides quantitative data in the form of proton spin density, T1, T2* and susceptibility maps as well as segmentation of white matter, gray matter and cerebrospinal fluid. STAGE uses vendors' product gradient echo sequences. It can be applied from 0.35 T to 7 T across all manufacturers producing similar results in contrast and quantification of the data. In this paper, we discuss the strengths and weaknesses of STAGE, demonstrate its contrast-to-noise (CNR) behavior relative to a large clinical data set and introduce a few new image contrasts derived from STAGE, including DIR images and a new concept referred to as true susceptibility weighted imaging (tSWI) linked to fluid attenuated inversion recovery (FLAIR) or tSWI-FLAIR for the evaluation of multiple sclerosis lesions. The robustness of STAGE T1 mapping was tested using the NIST/NIH phantom, while the reproducibility was tested by scanning a given individual ten times in one session and the same subject scanned once a week over a 12-week period. Assessment of the CNR for the enhanced T1W image (T1WE) showed a significantly better contrast between gray matter and white matter than conventional T1W images in both patients with Parkinson's disease and healthy controls. We also present some clinical cases using STAGE imaging in patients with stroke, metastasis, multiple sclerosis and a fetus with ventriculomegaly. Overall, STAGE is a comprehensive protocol that provides the clinician with numerous qualitative and quantitative images. Published by Elsevier Inc.

Entities:  

Keywords:  Multi-parametric magnetic resonance imaging; Quantitative magnetic resonance imaging; Quantitative susceptibility mapping; Strategically acquired gradient echo; Susceptibility weighted imaging; T1 mapping

Year:  2019        PMID: 31629075     DOI: 10.1016/j.mri.2019.09.006

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  11 in total

1.  Quantitative MRI using STrategically Acquired Gradient Echo (STAGE): optimization for 1.5 T scanners and T1 relaxation map validation.

Authors:  Alice Pirastru; Yongsheng Chen; Laura Pelizzari; Francesca Baglio; Mario Clerici; E Mark Haacke; Maria Marcella Laganà
Journal:  Eur Radiol       Date:  2021-01-06       Impact factor: 5.315

2.  Rapid multicontrast brain imaging on a 0.35T MR-linac.

Authors:  Siamak P Nejad-Davarani; Niloufar Zakariaei; Yongsheng Chen; E Mark Haacke; Newton J Hurst; M Salim Siddiqui; Lonni R Schultz; James M Snyder; Tobias Walbert; Carri K Glide-Hurst
Journal:  Med Phys       Date:  2020-07-06       Impact factor: 4.071

Review 3.  Primary Multiparametric Quantitative Brain MRI: State-of-the-Art Relaxometric and Proton Density Mapping Techniques.

Authors:  Hernán Jara; Osamu Sakai; Ezequiel Farrher; Ana-Maria Oros-Peusquens; N Jon Shah; David C Alsop; Kathryn E Keenan
Journal:  Radiology       Date:  2022-08-30       Impact factor: 29.146

4.  Quantitative susceptibility mapping as a measure of cerebral oxygenation in neonatal piglets.

Authors:  Brenda L Bartnik-Olson; Arlin B Blood; Michael H Terry; Shawn Fl Hanson; Christopher Day; Daniel Kido; Paggie Kim
Journal:  J Cereb Blood Flow Metab       Date:  2021-12-08       Impact factor: 6.960

5.  Three-dimensional simultaneous brain mapping of T1, T2, T2 and magnetic susceptibility with MR Multitasking.

Authors:  Tianle Cao; Sen Ma; Nan Wang; Sara Gharabaghi; Yibin Xie; Zhaoyang Fan; Elliot Hogg; Chaowei Wu; Fei Han; Michele Tagliati; E Mark Haacke; Anthony G Christodoulou; Debiao Li
Journal:  Magn Reson Med       Date:  2021-10-27       Impact factor: 3.737

Review 6.  PET/MRI in Pediatric Neuroimaging: Primer for Clinical Practice.

Authors:  C Pedersen; M Aboian; J E McConathy; H Daldrup-Link; A M Franceschi
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-05       Impact factor: 4.966

7.  Iron Content in Deep Gray Matter as a Function of Age Using Quantitative Susceptibility Mapping: A Multicenter Study.

Authors:  Yan Li; Sean K Sethi; Chunyan Zhang; Yanwei Miao; Kiran Kumar Yerramsetty; Vinay Kumar Palutla; Sara Gharabaghi; Chengyan Wang; Naying He; Jingliang Cheng; Fuhua Yan; Ewart Mark Haacke
Journal:  Front Neurosci       Date:  2021-01-06       Impact factor: 4.677

Review 8.  An Overview of Venous Abnormalities Related to the Development of Lesions in Multiple Sclerosis.

Authors:  E Mark Haacke; Yulin Ge; Sean K Sethi; Sagar Buch; Paolo Zamboni
Journal:  Front Neurol       Date:  2021-04-26       Impact factor: 4.003

9.  All Central Nervous System Neuro- and Vascular-Communication Channels Are Surrounded With Cerebrospinal Fluid.

Authors:  Lara M Fahmy; Yongsheng Chen; Stephanie Xuan; E Mark Haacke; Jiani Hu; Quan Jiang
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.003

10.  Multi-Echo Quantitative Susceptibility Mapping for Strategically Acquired Gradient Echo (STAGE) Imaging.

Authors:  Sara Gharabaghi; Saifeng Liu; Ying Wang; Yongsheng Chen; Sagar Buch; Mojtaba Jokar; Thomas Wischgoll; Nasser H Kashou; Chunyan Zhang; Bo Wu; Jingliang Cheng; E Mark Haacke
Journal:  Front Neurosci       Date:  2020-10-23       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.